GLIVEC for Chromosome analysis abnormal: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where GLIVEC was used for Chromosome analysis abnormal.
Most Reported Side Effects for GLIVEC
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 628 | 63.1% | 628 | 14 |
| Malignant neoplasm progression | 60 | 6.0% | 53 | 12 |
| Gastrointestinal stromal tumour | 40 | 4.0% | 30 | 12 |
| Chronic myeloid leukaemia | 38 | 3.8% | 34 | 6 |
| Anaemia | 30 | 3.0% | 18 | 13 |
| Second primary malignancy | 27 | 2.7% | 5 | 12 |
| Pyrexia | 21 | 2.1% | 16 | 9 |
| Blast crisis in myelogenous leukaemia | 20 | 2.0% | 20 | 3 |
| Dyspnoea | 19 | 1.9% | 14 | 9 |
| Malaise | 16 | 1.6% | 7 | 6 |
| Thrombocytopenia | 16 | 1.6% | 10 | 5 |
| Vomiting | 16 | 1.6% | 9 | 11 |
| Diarrhoea | 15 | 1.5% | 6 | 8 |
| General physical health deterioration | 15 | 1.5% | 13 | 8 |
| Nausea | 15 | 1.5% | 10 | 8 |
Other Indications for GLIVEC
Chronic myeloid leukaemia (636)
Gastrointestinal stromal tumour (231)
Acute lymphocytic leukaemia (61)
Gastrointestinal neoplasm (61)
Acute myeloid leukaemia (10)
Off label use (6)